+ Stefano Bertuzzi Ph.D. - Featured speaker, Director, Science Policy, Office of the Director, National Institutes of Health
+ Carolyn Compton, M.D., Ph.D.- Featured speaker, Director of the Office of Biorepositories and Biospecimen Research, National Cancer Institute
+ Jamila Louahed Ph.D.- Featured speaker, Director, Head of Research and Development, Cancer Immunotherapeutics, GlaxoSmithKline Biologicals
+ Dan Chelsky, Ph.D., Chief Scientific Officer, Caprion
+ Timothy R. Church, Professor, Department of Environmental Health Sciences, School of Public Health, University of Minnesota
+ Craig Davis, Director, Translational Oncology, Pfizer
+ Lisa Freeman-Cook, Ph.D., Senior Research and Development Manager, Life Technologies
+ Denise Geiger, Ph.D., Director, John T. Mather Memorial Hospital
+ Andrew Grupe, Ph.D, Senior Director, Pharmacogenomics, Celera
+ Leif Hakansson, M.D., Ph.D., Associate Professor, Vice chairman BDA, Chairman of the BDA Immunotherapy Working Group, CEO, CanImGuide Therapeutics AB
+ Dave S.B. Hoon, Ph.D, Director, Department Molecular Oncology, John Wayne Cancer Institute
+ Stephen Johnston, Ph.D., Director, Center for Innovations in Medicine, The Biodesign Institute, Arizona State University
+ Myla Lai-Goldman, Chief Executive Officer, CancerGuide Diagnostics
+ Thomas Li, Ph.D., FACB, FAAAAI, Senior Director, Technology Management, US Chief Technology Office, F. Hoffmann-La Roche Ltd
+ Stephen Little, Ph.D., Vice President, Personalized Healthcare, DxS Diagnostics
+ Andrey Loboda, Ph.D., Oncology Molecular Profiling, Merck Laboratories
+ Anna Lokshin, Ph.D., Associate Professor, University of Pittsburgh
+ Diane Longo, Scientist, Nodality
+ Raj Puri, M.D. Ph.D., Director, Division of Cellular and Gene Therapies, Office of Cellular, Tissue and Gene Therapies, FDA/CBER
+ Nathalie Scholler, M.D., Ph.D, Assistant Professor, Department of Obstetrics and Gynecology, University of Pennsylvania School of Medicine
+ Ginette Serrero, Ph.D., Chief Executive Officer, A&G Pharmaceutical
+ Andrew Schade, M.D., Ph.D, Medical Advisor, Eli Lilly and Company
+ Anthony P. Shuber, Chief Technology Officer, Co-Founder, Predictive Biosciences
+ Alan Spatz, M.D., Director,Pathology Department, Jewish General Hospital, Professor, Pathology and Oncology, McGill University
+ Shabnam Tangri, Ph.D., Director, Clinical Science and Technology, Biogen Idec
+ Ali Torkamani, Ph.D., Assistant Professor, Molecular and Experimental Medicine, Scripps Research Institute
+ Wim Van Criekinge, Ph.D., Vice President, Biomarker and Pharmacogenomics Research, Oncomethylome

Click here for a full speaker List

Refer a friend and win! If you refer this conference to any of your colleagues and they register to attend, you will receive $50 for every person that signs up. Once you forward the conference information to your colleagues, simply send a list of their names and contact information and the conference you are referring to infogtcbio@gtcbio.com and we will keep record until your colleague signs up!